Analysis of the hMSH2 Gene Variants in Head and Neck Cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  DNA and Cell Biology

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/dna.2009.1013PMID 20438357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer

  2010cited by this paper
• Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck

  2009cited by this paper
• CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.

  2009cited by this paper
• The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population

  2008cited by this paper
• Implications of mismatch repair genes hMLH1 and hMSH2 in patients with sporadic renal cell carcinoma

  2008cited by this paper
• Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.

  2008cited by this paper
• Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.

  2008cited by this paper
• Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers

  2008cited by this paper
• Genetic polymorphisms and head and neck cancer risk (Review).

  2008influential reference
• Mechanisms of pathogenicity in human MSH2 missense mutants

  2008cited by this paper
• Structure of the human MutSalpha DNA lesion recognition complex.

  2007cited by this paper
• Polymorphism in the hMSH2 gene (gISV12-6T > C) is a prognostic factor in non-small cell lung cancer.

  2007cited by this paper
• Mismatch Repair Genes hMLH1 and hMSH2 May Not Play an Essential Role in Breast Carcinogenesis

  2007cited by this paper
• Functional Characterization of Pathogenic Human MSH2 Missense Mutations in Saccharomyces cerevisiae

  2007cited by this paper
• Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing

  2006cited by this paper
• In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects

  2006cited by this paper
• Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.

  2006cited by this paper
• Head and neck cancer: past, present and future

  2006cited by this paper
• Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer

  2006cited by this paper
• Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.

  2006influential reference
• Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma

  2005cited by this paper
• Polymorphisms of the DNA Mismatch Repair Gene HMSH2 in Breast Cancer Occurence and Progression

  2005influential reference
• Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer

  2004influential reference
• Mutation Analysis of hMSH2 and hMLH1 in Colorectal Cancer Patients in India

  2004cited by this paper
• Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.

  2004cited by this paper
• Genotyping Possible Polymorphic Variants of Human Mismatch Repair Genes in Healthy Korean Individuals and Sporadic Colorectal Cancer Patients

  2004cited by this paper
• Molecular pathology of head‐and‐neck cancer

  2004influential reference
• Polymorphism in the hMSH2 gene (gIVS 12-6T-->C) and risk of non-Hodgkin lymphoma in a Japanese population.

  2003cited by this paper
• Analysis of the Polymorphism [gIVS12-6T≫C] in the hMSH2 Gene in Lymphoma and Leukemia

  2003influential reference
• An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents.

  2003influential reference
• Molecular pathology of head and neck cancer.

  2002cited by this paper
• A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas.

  2002cited by this paper
• Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review.

  2002cited by this paper
• Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1

  2001cited by this paper
• hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.

  2001cited by this paper
• The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

  2001cited by this paper
• Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control.

  2000cited by this paper
• Mismatch repair defects in cancer.

  2000cited by this paper
• Drug metabolism polymorphisms as modulators of cancer susceptibility.

  1999cited by this paper
• Replication errors: cha(lle)nging the genome

  1998cited by this paper
• Reduced DNA repair capacity in head and neck cancer patients.

  1998cited by this paper
• Eukaryotic mismatch repair: an update.

  1998cited by this paper
• Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?

  1998cited by this paper
• An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer.

  1997influential reference
• MSH2 sequence variations and inherited colorectal cancer susceptibility.

  1996cited by this paper
• Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines.

  1995cited by this paper
• A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis.

  1995cited by this paper
• MSH2 deficient mice are viable and susceptible to lymphoid tumours

  1995cited by this paper
• Purified human MSH2 protein binds to DNA containing mismatched nucleotides.

  1994cited by this paper
• Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

  1993cited by this paper
• The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

  1993cited by this paper
• Head and neck cancer.

  1991influential reference

• Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma

  2022influential citation
• Role of Genetic Polymorphisms in Breast Cancer

  2021cites this paper
• DNA repair systems

  2014cites this paper
• Association between the hMSH2 IVS12-6 T>C polymorphism and cancer risk: A meta-analysis.

  2011cites this paper
• Association between the hMSH 2 IVS 12-6 T > C polymorphism and cancer risk : A meta-analysis

  2011cites this paper